41 search results for “stelt” in the Staff website
-
Michael van der SteltISSC
-
Sanne van der SteltFaculty of Law
-
Mario van der SteltFaculty of Science
-
HR team stelt zich voor
Even voorstellen het HR team stelt zich voor
-
Wouter DrieverFaculty of Science
-
Ioana BelcinFaculty of Science
-
Nick PuijmbroeckFaculty of Science
-
Emanuele BerardiFaculty of Science
-
Finally solved: how the body's own marijuana spreads through the brain
Since its discovery thirty years ago, it remained a mystery: how does the body’s own marijuana move between nerve cells in the brain? Mario van der Stelt and his research group have now uncovered the answer. This insight could aid the development of new treatments for pain and neurological disorders…
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Scouring the brain for causes of psychiatric illnesses
What happens in the brains of people with psychiatric illnesses? With a €23.23 million gravity grant, scientists from different fields will search for biological causes over the next decade. ‘By joining forces, we hope to improve diagnosis and treatment for patients with these diseases.’
-
From droplets in the freezer to the inception of a potent new antibiotic
What started as an idea during a social gathering led to an unexpected breakthrough in research on resistant bacteria. Biologists and chemists from Leiden developed a new substance that proves to be effective against bacteria resistant to antibiotics. They published their discovery in Nature Chemist…
-
The Erasmus+ grant opens doors
What is it like to participate in the Erasmus+ grant programme as a Master's student from Ukraine? Yevhenii Radchenko did an eight-month internship at Leiden University in 2018. Soon after, he returned as a PhD candidate. 'You have little to lose, but a lot to gain.'
-
EUFEPS congres
EUFEPS Women in Pharmaceutical Sciences Award for Jara Bouma
-
Leiden Science rings in 2025 with inspiring speeches and happy winners
An impressive speech by Dean Jasper Knoester, a lecture by top researcher Mario van der Stelt about brain messengers, and the presentation of the faculty awards. 2025 begins on a hopeful and festive note, with a toast to a year of fruitful collaboration within and beyond the faculty.
-
Three days of fun in the Gorlaeus garden: this was the We are Science Week
Sunshine, ice cream, coffee, and plenty of good vibes. Once again, students and staff made the most of the We are Science Week. Relive some of the highlights with our photo report!
-
Selective cannabinoid CB2 receptor activation in Nature Communications
This March, Jara Bouma, Cas van der Horst and Laura Heitman from the Division of Drug Discovery and Safety and Laura de Paus, Richard van den Berg, Anthe Janssen and Mario van der Stelt from the LIC joined forces to determine how some drugs can specifically target the cannabinoid CB2 receptor (CB2R)…
-
New potential drug suppresses chemotherapy induced neuropathic pain
Oncode Investigator Mario van der Stelt and his colleagues have discovered a new potential drug that suppresses chemotherapy induced neuropathic pain.
-
‘To truly understand the brain, we must understand the chemistry’
How do fats and enzymes in the brain contribute to multiple sclerosis? In his PhD research, Daan van der Vliet combined chemistry and neuroscience to gain new insights into how brain disorders develop.
-
Oncode Accelerator funds preclinical development of cancer therapies
Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.
-
The molecular secrets of medicinal cannabis
Chronic pain, nausea or vomiting due to chemotherapy. If you suffer from such ailments, medicinal cannabis can be a godsend. Though a downside is that it can make patients high. Therefore, Leiden researchers from the Oncode Institute are investigating alternatives that do not make you high. In Nature…
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
National Growth Fund invests many millions in faster and more sustainable (cancer) drug development
On 14 April, the National Growth Fund awarded million euros in grants to two consortia in which Leiden's science faculty is involved. Pharma-NL will receive 80 million euros and Oncode-PACT 325 million euros. Pharma-NL wants to make medicines available to the patient faster and more sustainably. Oncode-PACT…
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.
-
New Year's Reception
Conference
-
Gravitation funding for five projects with Leiden researchers
The Advanced Nano-electrochemistry Institute Of the Netherlands (ANION) consortium will receive 23.6m euros in Gravitation funding for research on important electrochemical processes for energy transition. An additional four consortia with members from Leiden have also been awarded funding.
-
Jasper's day
Jasper Knoester is the dean of the Faculty of Science. How is he doing, what exactly does he do and what does his day look like? In each newsletter, Jasper gives an insight into his life.
-
Powerful new Leiden 'super antibiotic' may overcome resistance
The prestigious journal Science Translational Medicine has published a study by researchers from the Institute of Biology Leiden (IBL) on a potent new antibiotic that can overcome resistance. ‘The idea was to tweak the original antibiotic and create a next-generation drug’, says Nathaniel Martin, professor…
-
Dutch Research Council Open Science Fund grants for five Leiden projects
Five projects with a lead applicant from Leiden will receive an Open Science Fund grant from the Dutch Research Council (NWO).
-
A chemical biology approach to explore lipid metabolism in neurological disorders
PhD defence
-
Microglial lipid metabolism: a delicate balance
PhD defence
-
Design and Synthesis of Click Lipids as Tools to Study Immune Cell Metabolism
PhD defence
-
It's about time
PhD defence
-
Development of New Chemical Tools to Study the Cannabinoid Receptor Type 2
PhD defence
-
Release and transport of endocannabinoids
PhD defence
-
Discovery of selective diacylglycerol lipase β inhibitors
PhD defence
-
MAGL modulators - Structure-guided optimisation and characterisation
PhD defence
-
Transglycosylation of N-acylethanolamines
PhD defence
-
CellEKT: a chemical proteomics platform to study the kinome
PhD defence
-
News in a Glasshouse: Media, Publics, and Senses of Belonging in the Dutch Caribbean
PhD defence
-
Spectral imaging and tomographic reconstruction methods for industrial applications
PhD defence